As of January 22, 2025, Spruce Biosciences (SPRB) has a market cap of $15.592 million USD. According to our data, Spruce Biosciences is ranked No.8701 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $15.59 M |
-10.12%
|
Dec 31, 2024 | $17.35 M |
-85.67%
|
Dec 29, 2023 | $0.12 B |
167.09%
|
Dec 30, 2022 | $45.31 M |
-75.40%
|
Dec 31, 2021 | $0.18 B |
-81.65%
|
Dec 31, 2020 | $1.00 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Neurocrine Biosciences
NBIX
|
$14.86 B |
-0.000 M
|
USA
|
Ultragenyx
RARE
|
$3.97 B |
0.000 M
|
USA
|
Ascendis Pharma
ASND
|
$7.53 B |
0.000 M
|
Denmark
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Rhythm Pharmaceuticals
RYTM
|
$3.52 B |
0.000 M
|
USA
|
Crinetics Pharmaceuticals
CRNX
|
$3.58 B |
0.000 M
|
USA
|
Corcept Therapeutics
CORT
|
$6.18 B |
0.000 M
|
USA
|
Xeris Pharmaceuticals
XERS
|
$0.49 B |
-0.000 M
|
USA
|
Soleno Therapeutics
SLNO
|
$2.09 B |
0.000 M
|
USA
|
Market Cap | = | SPRB Stock Price | * | SPRB Shares Outstanding |
= | $0.38 | * | 41.30 M | |
= | $15.59 M |